Who has invested in Tune Therapeutics?

NEA are named among the investors backing Tune Therapeutics.

Tune Therapeutics Funding: $200M Raised, Series B (2025)

Tune Therapeutics funding overview

Tune Therapeutics is based in Seattle. Tune Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2025. The round record for Tune Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include NEA.

Tune Therapeutics at a glance

Total raised: $200M
Latest round: Series B
Latest round date: January 2025
Headquarters: Seattle
Notable investors: NEA

Frequently asked about Tune Therapeutics funding

How much has Tune Therapeutics raised?: Tune Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Tune Therapeutics?: NEA are named among the investors backing Tune Therapeutics.
What was the latest Tune Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2025.
Where is Tune Therapeutics based?: Tune Therapeutics is based in Seattle.
When did Tune Therapeutics last raise?: The last disclosed Tune Therapeutics round closed in January 2025 at Series B.

Totals shown for Tune Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.

Tune Therapeutics Funding: $200M Raised, Series B (2025)

Tune Therapeutics funding overview

Tune Therapeutics at a glance

Frequently asked about Tune Therapeutics funding

Companies related to Tune Therapeutics (36)

Browse related funding lists (5)